STAT
JULY 26, 2024
A decade ago, Pfizer began investing heavily in gene therapy, bringing in experimental treatments for a range of genetic diseases, pumping $800 million into “state-of-the-art” manufacturing facilities and announcing its intention to become an “industry leader” that would deliver “one-time, transformative therapies” for rare diseases.
PharmaVoice
JULY 26, 2024
Citius Pharmaceuticals CEO Leonard Mazur has personally invested $22.5 million into the company, which is fast approaching a potential turning point.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JULY 26, 2024
About 5% of Americans require skilled care at some point as they age. The horrific reports of more than 200,000 deaths of nursing home residents and staff during the Covid-19 pandemic put the nursing home industry under intense national scrutiny. But not all nursing homes experienced this level of tragedy and loss. One major reason why some fared better than others was adequate nurse staffing.
pharmaphorum
JULY 26, 2024
Leading figures from industry and academia, including AstraZeneca, have urged UK PM Keir Starmer to turn the Oxford-Cambridge region into the "crown jewel" of his industrial growth plan
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
JULY 26, 2024
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. I’m Brittany Trang, STAT health tech reporter and your new Friday morning host.
The Pharmacist
JULY 26, 2024
Some 423,310 Pharmacy First consultations were delivered in the first three months of the service, official figures from the NHS Business Service Authority (NHSBSA) have revealed. A total of 9,976 community pharmacies claimed payments for the service, although the number of those claiming on a monthly basis in February, March and April appears to be […] The post BREAKING: Over 423,000 Pharmacy First consultations delivered in first three months appeared first on The Pharmacist.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
JULY 26, 2024
CHMP recommends against approval of Eisai, Biogen's Alzheimer's disease therapy Leqembi, saying side effects outweigh its benefits
STAT
JULY 26, 2024
LONDON — European regulators on Friday said that an Alzheimer’s therapy from Eisai and Biogen should be rejected, again diverging from their U.S. counterparts on a medicine for a condition where treatments are desperately needed. In a statement, the regulators said that the benefits of Leqembi did not outweigh the risks of potentially dangerous side effects.
Drug Patent Watch
JULY 26, 2024
Chiral switching, the practice of developing a single enantiomer from a previously approved racemic drug, has been a significant strategy in the pharmaceutical industry for decades.
STAT
JULY 26, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is fairly modest. We hope to catch up on our reading, spend time with our Pharmalot ancestor, and promenade with the official mascots. We also hope to hold another listening party, where the rotation will likely feature this , this , this , and this.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharma Times
JULY 26, 2024
Researchers predicted the onset of 67 diseases, out-performing current standard models
STAT
JULY 26, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve made it to the end of the week! I don’t know about you, but it’s felt like an especially long week for me. It’s probably cause of all the news that we will get into right now.
Outsourcing Pharma
JULY 26, 2024
Discover the groundbreaking work of Cure51, co-founded by Nicolas Wolikow and Simon Istolainen, revolutionizing cancer treatment through advanced AI and biotechnology.
STAT
JULY 26, 2024
“Regulation is stifling innovation” seems to be a prevailing opinion among medtech leaders who believe the Food and Drug Administration’s rules are slowing medical device advancements — especially when it comes to software. I couldn’t disagree more. As someone who has led artificial intelligence (AI) and machine learning (ML) efforts at Amgen, I’ve seen firsthand how vital these regulations are for keeping patients safe.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharma Times
JULY 26, 2024
The new Human Gut Microbiome Atlas could help treat conditions including IBS and AMR
STAT
JULY 26, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Express Pharma
JULY 26, 2024
Medidata , a Dassault Systèmes brand and provider of clinical trial solutions to the life sciences industry, announced Eisai Inc the US pharmaceutical subsidiary of Tokyo-based Eisai Co, as one of the first customers to harness its recently announced AI-driven Medidata Clinical Data Studio. Eisai Inc aims to leverage this innovative data experience to gain control over its clinical data, enable the execution of scalable and complex clinical trials, and enhance patient experience.
The Pharmacist
JULY 26, 2024
Almost half (46%) of UK adults were unaware of Pharmacy First around three months into the service being available in England, a survey has shown. However nearly three-quarters (73%) thought that pharmacists should be able to update medical records with any advice or treatment supplied – up from 65% last year. The survey was conducted […] The post Nearly half of UK adults 'unaware' of Pharmacy First, survey suggests appeared first on The Pharmacist.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Express Pharma
JULY 26, 2024
NovaLead Pharma announced that the drug regulator in India, CDSCO has approved their patented repurposed drug for the treatment of Diabetic Foot Ulcer (DFU). DFU is one of the most prevalent complications caused by chronic diabetes. The approval of NovaLead’s patented repurposed drug is significant because DFU is the leading cause of lower limb amputations globally, with about 100,000 annual incidences in India alone.
pharmaphorum
JULY 26, 2024
Discover the innovative work of Steven Damon, the CEO of Micron Biomedical, a company specialising in microneedle technology for improved healthcare delivery. Learn about his cutting-edge innovations in the field.
Express Pharma
JULY 26, 2024
Suven Pharmaceuticals recently received approval from the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) for the proposed merger with Cohance Lifesciences. A joint application by Suven and Cohanc has been filed before NCLT. Expected timelines for the completion of the merger process as indicated prior: 12-15 months. The newly formed company will operate three main verticals: Pharma CDMO, Agrochemicals CDMO, and API manufacturing.
pharmaphorum
JULY 26, 2024
Discover 5 effective strategies for biopharma companies to optimize patient recruitment in clinical trials. Learn how to enhance recruitment processes and increase patient participation.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Pharmacist
JULY 26, 2024
The Scottish Government has said it is 'aware' of issues following the introduction of a new payment system for community pharmacies, and has been assured that any incorrect payments have been or are being 'rectified'. And it said it was engaging with stakeholders as it continued to monitor the situation. Issues with the Data Capture […] The post Scottish Government 'monitoring' payment system issues appeared first on The Pharmacist.
pharmaphorum
JULY 26, 2024
Discover the top 7 trends from the Cannes Lions Festival that pharma professionals should be aware of. Stay ahead of the game with these creative insights.
Outsourcing Pharma
JULY 26, 2024
The approval of donanemab marks a significant breakthrough in Alzheimer's treatment, promising transformative changes in patient care and research.
Express Pharma
JULY 26, 2024
India is making significant strides in the nutraceutical industry with the launch of NutrifyGenie AI, a revolutionary technology set to transform new product ideation and commercialisation globally. Nutraceuticals, often seen as proactive health investments, are experiencing a strong compound annual growth rate (CAGR) of 7.8 per cent. This growth drives the need for innovative product development and new botanical and biochemical discoveries to enhance health outcomes.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
BioPharma Dive
JULY 26, 2024
Eisai plans to appeal the EMA’s negative recommendation, hoping to break into a market analysts expect could eventually bring billions of dollars in sales for the Alzheimer’s drug.
Big Molecule Watch
JULY 26, 2024
On July 22, 2024, STADA Arzeimittel AG (“STADA”) and Alvotech announced the launch of ustekinumab biosimilar AVT04 under the name UZPROVO® across a majority of European countries. UZPROVO®, the first approved ustekinumab biosimilar to STELARA® in Europe, is indicated for the treatment of Crohn’s disease, psoriasis and psoriatic arthritis. As we previously reported, Alvotech and STADA announced that the European Commission issued a marketing authorization for AVT04 in January 2024, and Alvotech
Pharmafile
JULY 26, 2024
Clinical-stage biopharmaceutical company AC Immune announced that the US Food and Drug Administration (FDA) has granted its Alzheimer’s disease (AD) candidate ACI-35.030 (now called JNJ-2056) Fast Track designation. ACI-35.030 is an active-immunotherapy targeting phosphorylated Tau (pTau). It has been shown to induce a strong polyclonal antibody response against Tau aggregation, thereby potentially reducing the pathological […] The post AC Immune’s pTau-targeting immunotherapy awarded Fast
pharmaphorum
JULY 26, 2024
Vaccination with GSK's recombinant shingles vaccine Shingrix could delay the onset of dementia, according to researchers in the UK.A study published in Nature Medicine suggests that people administered Shingrix have a lower risk of dementia compared to those given Zostavax - an older shingles shot based on a different technology – and builds on earlier research suggesting a benefit from this type of vaccination.
BioPharma Dive
JULY 26, 2024
Glycomimetics and Cue Biopharma both revealed layoffs. Elsewhere, AbbVie’s earnings impressed Wall Street and an FDA panel recommended changing testing requirements for some lung cancer drugs.
Expert insights. Personalized for you.
358 
Let's personalize your content